
A Drug Utilization Study of Cognition Enhancers in Dementia in a Tertiary Care Hospital in Mumbai
Author(s) -
Karan Thakkar,
Shaurya Suman,
Gauri Billa
Publication year - 2014
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2014/7998.4354
Subject(s) - rivastigmine , memantine , dementia , donepezil , piracetam , medicine , medical prescription , polypharmacy , psychiatry , drug , delirium , intensive care medicine , pharmacology , disease
Cognitive decline is one of the important factors undermining the quality of life in geriatric patients. Although the WHO has declared 'Dementia' as a priority health condition.Cognitive neuropharmacology is still in its infancy and there is no general consensus on the use of cognition enhancing (CE) drugs in humans. Since drug utilization data of CEs in dementia are scarce, we conducted a study to describe the observed patterns of CE drug use, compare it to the current recommendations and conduct a preliminary cost analysis.